Q BioMed, Jubilant Radiopharma to partner

By AuntMinnie.com staff writers

October 3, 2019 -- Biotech company Q BioMed and Jubilant Radiopharma have announced an agreement regarding the distribution of a cancer palliation radiopharmaceutical in the U.S.

Jubilant will distribute Q BioMed's Metastron (strontium-89 chloride injection) metastatic bone cancer palliation drug.

Distribution will begin after the U.S. Food and Drug Administration (FDA) approves Metastron, Q BioMed said.


Copyright © 2019 AuntMinnie.com
 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: